Healthcare
EBR Systems, Inc.(EBRCZ)
Live Price
Offline$0.2779
+48.56% today
1Y Change
-44.35%
Window
Jun 25, 2025 โ Jun 24, 2026
- Market Cap
- $180.00M
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 0.0%
Coverage: 254 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
EBR Systems, Inc. (EBRCZ) is a Healthcare stock with a market cap of $180.00M and listed on OTC. The stock last traded around $0.28 and down 44.3% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow -37.0% with operating margin -2836.6% and ROIC -54.9%. Valuation already assumes a fairly strong business story at price/sales 113.1. Stock Foundry combines EBRCZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
-2836.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near -2836.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -7.3% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +4.8% | -17.3% | -58.4% |
2026 Mar 18, 2026 | +3.2% | -8.0% | -4.6% | -4.7% |
2025 Nov 12, 2025 | โ | +0.0% | +0.0% | +16.7% |
Benchmark Edge
EBRCZ vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EBRCZ
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EBRCZ Max Drawdown
-84.41%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for EBRCZ and SPY.
Company Overview
EBR Systems, Inc.
Other OTC
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
- Leadership
- John Graham McCutcheon
- IPO Date
- Aug 31, 2023
- Employees
- 89
- Street Address
- 480 Oakmead Parkway
- Mailing
- Sunnyvale, CA, 94085
- Region
- Sunnyvale, CA, US
- Reporting Currency
- USD
- Investor Line
- 408 720 1906
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 113.1
- Price/Book
- 7.2
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- -37.0%
Profitability
- Gross Margin
- 30.2%
- Operating Margin
- -2836.6%
- Net Margin
- -3001.0%
- ROE
- -152.5%
- ROIC
- -54.9%
Balance Sheet
- Debt/Equity
- 2.29
- Current Ratio
- 5.20
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.